Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
2,890
+349
+14% +$179K 0.01% 1303
2026
Q1
$1.09M Sell
2,541
-218
-8% -$96K 0.01% 1355
2025
Q4
$920K Hold
2,759
﹤0.01% 1478
2025
Q3
$880K Buy
+2,759
New +$762K ﹤0.01% 1519
2025
Q2
Sell
-3,121
Closed -$577K 2898
2025
Q1
$577K Buy
+3,121
New +$721K ﹤0.01% 1659

Other funds holding NVMI

MetLife Investment Management's NVMI Position: Q2 2026 in Review

MetLife Investment Management increased its Nova (NVMI) stake by 14% in Q2 2026, buying an estimated $179K and bringing the position to 2,890 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1303.

MetLife Investment Management first reported a position in NVMI in Q1 2025 and has held it in 5 quarters since. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • MetLife Investment Management held 2,890 shares of Nova worth $1.53M as of Q2 2026.
  • MetLife Investment Management bought 349 Nova shares in Q2 2026, an estimated $179K.
  • Nova made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1303 holding.
  • MetLife Investment Management first reported a position in Nova in Q1 2025 and has held it in 5 quarters since.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.